Boehringer Ingelheim has officially launched a new, state-of-the-art Artificial Intelligence (AI) and Machine Learning (ML) center in London’s King’s Cross,…
Read More
Boehringer Ingelheim and Zai Lab Forge Clinical Collaboration to Pioneer Novel Combination Therapy for Aggressive Lung Cancers
Boehringer Ingelheim and Zai Lab have announced a significant clinical collaboration aimed at investigating a dual delta-like ligand 3 (DLL3)-targeting…
Read More
